Collegium Pharmaceutical, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Collegium Pharmaceutical, Inc. stock issued during period, value, new issues for the quarter ending 2017-12-31 was $22.83M, a 73.51% decline year-over-year.
- Collegium Pharmaceutical, Inc. stock issued during period, value, new issues for the quarter ending 2016-12-31 was $86.17M.
- Collegium Pharmaceutical, Inc. stock issued during period, value, new issues for the quarter ending 2016-09-30 was $0.00.
- Collegium Pharmaceutical, Inc. stock issued during period, value, new issues for the quarter ending 2016-06-30 was -$1.00K.
- Collegium Pharmaceutical, Inc. stock issued during period, value, new issues for fiscal 2017 was $34.28M, a 75.04% decline from fiscal 2016.
- Collegium Pharmaceutical, Inc. stock issued during period, value, new issues for fiscal 2016 was $137.34M, a 90.67% increase from fiscal 2015.
- Collegium Pharmaceutical, Inc. stock issued during period, value, new issues for fiscal 2015 was $72.03M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2017-12-31 | $22.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $34.28M 10-K · filed 2020-02-27 |
| 2016-12-31 | $86.17M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $137.34M 10-K · filed 2019-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2016-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | |
| 2016-03-31 | $51.17M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $72.03M 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |